All-stage Targeted Red Blood Cell Membrane-Coated Docetaxel Nanocrystals for Glioma Treatment

Yuan Ding,Qianzhu Xu,Zhilan Chai,Sunyi Wu,Weixia Xu,Jun Wang,Jianfen Zhou,Zimiao Luo,Yu Liu,Cao Xie,Linwei Lu,Weiyue Lu

DOI: https://doi.org/10.1016/j.jconrel.2024.03.055

IF: 11.467

2024-01-01

Journal of Controlled Release

Abstract:Challenges for glioma treatment with nanomedicines include physio-anatomical barriers (the blood-brain barrier and blood-brain tumor barrier), low drug loading capacity, and limited circulation time. Here, a red blood cell membrane-coated docetaxel drug nanocrystal (pV-RBCm-NC(DTX)), modified with pHA-VAP (pV) for all-stage targeting of glioma, was designed. The NC(DTX) core exhibited a high drug loading capacity but low in vivo stability, and the RBCm coating significantly enhanced the stability and prolonged in vivo circulation. Moreover, the Y-shaped targeting ligand pV was modified by a mild avidin-biotin interaction, which endowed RBCm-NC(DTX) with superior barrier-crossing ability and therapeutic efficacy. The integration of nanocrystal technology, cell membrane coating, and the avidin-biotin insertion method into this active targeting biomimetic formulation represents a promising drug delivery strategy for glioma.